NRx Pharmaceuticals achieved VAI status in Vai and is now seeking clearance for its KetAFree drug launch with the FDA.
1 report, 1 independent
Updated May 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NRx Pharmaceuticals achieved VAI status in Vai and is now seeking clearance for its KetAFree drug launch with the FDA.
Who's involved
What this event is mainly aboutVaiFDA
How it developed
Newest first. Tap a step to see who reported it.- NRx Pharmaceuticals is undergoing a first-cycle review of an ANDA for ketamine, noting its strategic importance for the U.S. military and VA.Sub-event
NRx Pharmaceuticals achieved VAI status in Vai and is now seeking clearance for its KetAFree drug launch with the FDA.1 source